Investors looking for international diversification beyond the United States have more choices than ever, and two that often come up in discussions are DFAI and VXUS. Both target equity exposure outside the U.S., yet they follow very different approaches. DFAI applies a systematic, factor-driven strategy focused mainly on developed markets, while VXUS provides broad, index-based coverage that includes both developed and emerging economies. I also checked this using Tickeron’s AI Screener to see how the two compare across key metrics. Comparing them helps clarify how the choice between active factor tilts and low-cost total-market indexing influences sector exposure, risk, and long-term results. Understanding these structural differences matters when building a resilient global allocation.
DFAI, from Dimensional Fund Advisors, is an actively managed ETF aimed at long-term capital appreciation. Instead of tracking an index, it uses a rules-based process that overweights companies with smaller market caps, lower relative prices, and higher profitability relative to the developed international universe. It references the MSCI World ex USA IMI Index but does not replicate it. The fund typically holds 3,500 to 3,900 securities, almost all in developed markets, with leading country allocations in Japan, the United Kingdom, Canada, France, and Switzerland. Sector exposure concentrates in financials, industrials, consumer discretionary, and health care. Top holdings include ASML Holding, Shell, HSBC, Nestlé, Novo Nordisk, Roche, AstraZeneca, SAP, Toyota, and TotalEnergies, though positions remain well diversified. The expense ratio stands at 0.18%, and the fund trades on NYSE Arca with solid liquidity and tight spreads.
VXUS, from Vanguard, is a passively managed ETF that tracks the FTSE Global All Cap ex US Index, a float-adjusted, market-cap-weighted benchmark spanning developed and emerging markets outside the United States. The fund stays fully invested in the common stocks of its target index. With approximately 8,600 holdings, it offers one of the widest international equity portfolios available, covering large-, mid-, and small-cap companies. Roughly 60–65% of assets sit in developed markets and about 30% in emerging markets, with top country exposure to Japan, China, the United Kingdom, Canada, India, and Taiwan. Sector weightings tilt toward financial services, technology, and industrials. Largest positions include Taiwan Semiconductor Manufacturing (TSM), Samsung Electronics, ASML, SK hynix, Tencent, HSBC, Roche, Shell, Royal Bank of Canada, and Novartis. VXUS carries a 0.05% expense ratio and trades on NASDAQ with strong liquidity.
International equities have attracted fresh interest as investors reevaluate U.S. valuations and pursue broader geographic diversification. Both funds respond to overlapping macro forces, including divergent central-bank policies among the Federal Reserve, European Central Bank, and Bank of Japan; shifts in the U.S. dollar that directly affect foreign returns; and ongoing Japanese corporate governance reforms supporting earnings momentum. Differences arise from their mandates. VXUS’s emerging-market exposure brings growth dynamics in Asia, semiconductor supply-chain concentration in Taiwan and South Korea, and currency risk in China and India. DFAI, by contrast, avoids emerging-market volatility and emphasizes value and higher-profitability companies in developed markets. Sector rotation, energy and materials pricing, and interest-rate expectations continue to influence relative positioning.
Recent market cycles show the funds diverging in line with their construction. DFAI’s factor tilts and developed-market focus have historically supported lower volatility and consistent benchmark outperformance, aided by value and profitability premiums along with Japanese equity strength. VXUS has gained from technology-led gains in emerging Asia, especially semiconductor names, which have driven periods of strong relative returns but also higher drawdowns and greater sensitivity to geopolitical and currency moves. From a positioning perspective, VXUS delivers broader diversification and lower costs, appealing as a default for index-focused investors. DFAI provides a more deliberate tilt toward companies with higher expected returns and has traded with lower volatility despite its higher fee. The choice ultimately depends on whether an investor prioritizes maximum breadth and minimal cost or a disciplined factor emphasis within developed markets.
When comparing ETFs like these, I often turn to Tickeron’s AI Screener for quick, customizable scans across technical patterns, fundamentals, volatility, and AI-driven signals. It helps surface relevant ideas and benchmark comparisons far more efficiently than manual work, and I find it particularly useful for refining views on factor tilts versus broad indexing before making allocation decisions.
After weighing structural strength, cost efficiency, diversification profile, trend consistency, and risk exposure, Tickeron’s AI currently favors DFAI. While VXUS offers a lower expense ratio and broader emerging-market diversification, DFAI’s disciplined, factor-based tilt toward profitability and value, its insulation from emerging-market volatility, and its history of lower volatility with consistent benchmark outperformance give it the stronger relative positioning under current conditions. The assessment is probabilistic and based on observable structural and trend characteristics rather than any short-term price move. This should not be read as personalized investment advice.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Moving Average Convergence Divergence (MACD) for VXUS turned positive on October 28, 2026. Looking at past instances where VXUS's MACD turned positive, the stock continued to rise in 40 of 45 cases over the following month. The odds of a continued upward trend are 89%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 55 of 63 cases where VXUS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on VXUS as a result. In 65 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
Following a +1.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where VXUS advanced for three days, in 279 of 340 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
VXUS moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for VXUS crossed bearishly below the 50-day moving average on September 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VXUS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The Aroon Indicator for VXUS entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ForeignLargeBlend